These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 24103729)

  • 1. Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease.
    O'Hare E; Scopes DI; Kim EM; Palmer P; Spanswick D; McMahon B; Amijee H; Nerou E; Treherne JM; Jeggo R
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):117-26. PubMed ID: 24103729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity.
    Scopes DI; O'Hare E; Jeggo R; Whyment AD; Spanswick D; Kim EM; Gannon J; Amijee H; Treherne JM
    Br J Pharmacol; 2012 Sep; 167(2):383-92. PubMed ID: 22913627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The N-methylated peptide SEN304 powerfully inhibits Aβ(1-42) toxicity by perturbing oligomer formation.
    Amijee H; Bate C; Williams A; Virdee J; Jeggo R; Spanswick D; Scopes DI; Treherne JM; Mazzitelli S; Chawner R; Eyers CE; Doig AJ
    Biochemistry; 2012 Oct; 51(42):8338-52. PubMed ID: 23025847
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orally available compound prevents deficits in memory caused by the Alzheimer amyloid-beta oligomers.
    Townsend M; Cleary JP; Mehta T; Hofmeister J; Lesne S; O'Hare E; Walsh DM; Selkoe DJ
    Ann Neurol; 2006 Dec; 60(6):668-76. PubMed ID: 17192927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orally bioavailable small molecule drug protects memory in Alzheimer's disease models.
    O'Hare E; Scopes DI; Kim EM; Palmer P; Jones M; Whyment AD; Spanswick D; Amijee H; Nerou E; McMahon B; Treherne JM; Jeggo R
    Neurobiol Aging; 2013 Apr; 34(4):1116-25. PubMed ID: 23164690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimization of d-Peptides for Aβ Monomer Binding Specificity Enhances Their Potential to Eliminate Toxic Aβ Oligomers.
    Klein AN; Ziehm T; van Groen T; Kadish I; Elfgen A; Tusche M; Thomaier M; Reiss K; Brener O; Gremer L; Kutzsche J; Willbold D
    ACS Chem Neurosci; 2017 Sep; 8(9):1889-1900. PubMed ID: 28581708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Erythropoietin improves synaptic plasticity and memory deficits by decrease of the neurotransmitter release probability in the rat model of Alzheimer's disease.
    Esmaeili Tazangi P; Moosavi SM; Shabani M; Haghani M
    Pharmacol Biochem Behav; 2015 Mar; 130():15-21. PubMed ID: 25553822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
    Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
    Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Alzheimer's amyloid toxicity with a tricyclic pyrone molecule in vitro and in vivo.
    Hong HS; Rana S; Barrigan L; Shi A; Zhang Y; Zhou F; Jin LW; Hua DH
    J Neurochem; 2009 Feb; 108(4):1097-1108. PubMed ID: 19141069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin prevents amyloid beta protein-induced impairment of long-term potentiation in rat hippocampus in vivo.
    Jing W; Guo F; Cheng L; Zhang JF; Qi JS
    Neurosci Lett; 2009 Feb; 450(3):306-10. PubMed ID: 19059464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Testing Aβ toxicity on primary CNS cultures using drug-screening microfluidic chips.
    Ruiz A; Joshi P; Mastrangelo R; Francolini M; Verderio C; Matteoli M
    Lab Chip; 2014 Aug; 14(15):2860-6. PubMed ID: 24914747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of Chunghyuldan from amyloid beta oligomer induced neuroinflammation in vitro and in vivo.
    Kim HG; Kim JY; Whang WW; Oh MS
    Can J Physiol Pharmacol; 2014 Jun; 92(6):429-37. PubMed ID: 24820962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal formulation of erythropoietin (EPO) showed potent protective activity against amyloid toxicity in the Aβ₂₅₋₃₅ non-transgenic mouse model of Alzheimer's disease.
    Maurice T; Mustafa MH; Desrumaux C; Keller E; Naert G; de la C García-Barceló M; Rodríguez Cruz Y; Garcia Rodríguez JC
    J Psychopharmacol; 2013 Nov; 27(11):1044-57. PubMed ID: 23813967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol prevents Aβ 25 35-inhibited long-term potentiation induction through enhancing survival of newborn neurons in the dentate gyrus.
    Wang XJ; Song XJ; Gao PH; Zhou XY; Zhou SN
    Int J Neurosci; 2016; 126(2):154-62. PubMed ID: 25567530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The potential of synthetic indolylquinoline derivatives for Aβ aggregation reduction by chemical chaperone activity.
    Chang KH; Chiu YJ; Chen SL; Huang CH; Lin CH; Lin TH; Lee CM; Ramesh C; Wu CH; Huang CC; Fung HC; Chen YC; Lin JY; Yao CF; Huang HJ; Lee-Chen GJ; Lee MC; Hsieh-Li HM
    Neuropharmacology; 2016 Feb; 101():309-19. PubMed ID: 26362358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of stemazole in a beta-amyloid injection rat model of Alzheimer's disease.
    Han M; Liu Y; Tan Q; Zhang B; Wang W; Liu J; Zhang XJ; Wang YY; Zhang JM
    Eur J Pharmacol; 2011 Apr; 657(1-3):104-10. PubMed ID: 21316359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dextran sulfate sodium inhibits amyloid-β oligomer binding to cellular prion protein.
    Aimi T; Suzuki K; Hoshino T; Mizushima T
    J Neurochem; 2015 Aug; 134(4):611-7. PubMed ID: 25963375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the neurotoxic species in Alzheimer's disease: inhibitors of Abeta oligomerization.
    De Felice FG; Vieira MN; Saraiva LM; Figueroa-Villar JD; Garcia-Abreu J; Liu R; Chang L; Klein WL; Ferreira ST
    FASEB J; 2004 Sep; 18(12):1366-72. PubMed ID: 15333579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.